1-1047614-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_198576.4(AGRN):​c.3558T>C​(p.Phe1186Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.907 in 1,612,940 control chromosomes in the GnomAD database, including 669,418 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.82 ( 53400 hom., cov: 35)
Exomes 𝑓: 0.92 ( 616018 hom. )

Consequence

AGRN
NM_198576.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.15

Publications

17 publications found
Variant links:
Genes affected
AGRN (HGNC:329): (agrin) This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2015]
AGRN Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • presynaptic congenital myasthenic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 1-1047614-T-C is Benign according to our data. Variant chr1-1047614-T-C is described in ClinVar as Benign. ClinVar VariationId is 128302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.15 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGRNNM_198576.4 linkc.3558T>C p.Phe1186Phe synonymous_variant Exon 21 of 36 ENST00000379370.7 NP_940978.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGRNENST00000379370.7 linkc.3558T>C p.Phe1186Phe synonymous_variant Exon 21 of 36 1 NM_198576.4 ENSP00000368678.2

Frequencies

GnomAD3 genomes
AF:
0.820
AC:
124694
AN:
152140
Hom.:
53403
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.538
Gnomad AMI
AF:
0.986
Gnomad AMR
AF:
0.896
Gnomad ASJ
AF:
0.924
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.957
Gnomad FIN
AF:
0.958
Gnomad MID
AF:
0.879
Gnomad NFE
AF:
0.920
Gnomad OTH
AF:
0.846
GnomAD2 exomes
AF:
0.908
AC:
227622
AN:
250598
AF XY:
0.916
show subpopulations
Gnomad AFR exome
AF:
0.525
Gnomad AMR exome
AF:
0.939
Gnomad ASJ exome
AF:
0.923
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.953
Gnomad NFE exome
AF:
0.917
Gnomad OTH exome
AF:
0.908
GnomAD4 exome
AF:
0.916
AC:
1337920
AN:
1460682
Hom.:
616018
Cov.:
92
AF XY:
0.918
AC XY:
667056
AN XY:
726632
show subpopulations
African (AFR)
AF:
0.516
AC:
17271
AN:
33480
American (AMR)
AF:
0.933
AC:
41707
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.920
AC:
24044
AN:
26136
East Asian (EAS)
AF:
1.00
AC:
39685
AN:
39700
South Asian (SAS)
AF:
0.952
AC:
82130
AN:
86258
European-Finnish (FIN)
AF:
0.951
AC:
49677
AN:
52244
Middle Eastern (MID)
AF:
0.864
AC:
4986
AN:
5768
European-Non Finnish (NFE)
AF:
0.921
AC:
1024039
AN:
1111990
Other (OTH)
AF:
0.901
AC:
54381
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
7666
15332
22999
30665
38331
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21476
42952
64428
85904
107380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.819
AC:
124724
AN:
152258
Hom.:
53400
Cov.:
35
AF XY:
0.825
AC XY:
61395
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.537
AC:
22307
AN:
41512
American (AMR)
AF:
0.896
AC:
13715
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.924
AC:
3207
AN:
3472
East Asian (EAS)
AF:
0.999
AC:
5174
AN:
5178
South Asian (SAS)
AF:
0.956
AC:
4621
AN:
4834
European-Finnish (FIN)
AF:
0.958
AC:
10178
AN:
10624
Middle Eastern (MID)
AF:
0.877
AC:
256
AN:
292
European-Non Finnish (NFE)
AF:
0.920
AC:
62575
AN:
68016
Other (OTH)
AF:
0.848
AC:
1792
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
947
1894
2840
3787
4734
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
858
1716
2574
3432
4290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.878
Hom.:
34847
Bravo
AF:
0.800
Asia WGS
AF:
0.947
AC:
3292
AN:
3478
EpiCase
AF:
0.915
EpiControl
AF:
0.907

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 19, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Congenital myasthenic syndrome 8 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
6.6
DANN
Benign
0.32
PhyloP100
2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10267; hg19: chr1-982994; COSMIC: COSV65071416; COSMIC: COSV65071416; API